AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24861802 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus three in‐hospital professional breastfeeding support sessions (30-45 minutes each)
Number of subjects: 722
Study 24861802 — intervention group
Group type: COMPARATOR
Intervention: Standard postnatal maternity care
Number of subjects: 722
Study 22038209 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative enteral nutrition (EN)
Number of subjects: 3
Study 22038209 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative enteral nutrition (EN) with hyperthermic intraoperative intraperitoneal chemotherapy (HIIC)
Number of subjects: 3
Study 22038209 — intervention group
Group type: COMPARATOR
Intervention: Postoperative parenteral nutrition (PN) with hyperthermic intraoperative intraperitoneal chemotherapy (HIIC)
Number of subjects: 3
Study 19744620 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain natriuretic peptide (BNP) > or = 105 pg/ml
Number of subjects: 269
Study 19744620 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP assessment
Number of subjects: 269
Study 17686797 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic group: no aspiration, rapid injection and rapid withdrawal
Number of subjects: 113
Study 17686797 — intervention group
Group type: COMPARATOR
Intervention: Standard of care group: slow aspiration prior to injection, slow injection and slow withdrawal
Number of subjects: 113
Study 15262616 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled studies (RCTs)
Number of subjects: 0
Study 15262616 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturalistic studies
Number of subjects: 0
Study 15262616 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence from RCTs
Number of subjects: 0
Study 15262616 — intervention group
Group type: EXPERIMENTAL
Intervention: Catalogues for levels of evidence
Number of subjects: 0
Study 15262616 — intervention group
Group type: EXPERIMENTAL
Intervention: New research agenda for naturalistic studies
Number of subjects: 0
Study 11468761 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis using individual patient data
Number of subjects: 0
Study 11468761 — intervention group
Group type: EXPERIMENTAL
Intervention: SAS PROC MIXED and MLwiN
Number of subjects: 0
Study 11468761 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian framework using BUGS
Number of subjects: 0
Study 9753050 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/d aspirin for 2 weeks
Number of subjects: 0
Study 9753050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7800210 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg acetylsalicylic acid daily (group B)
Number of subjects: 137
Study 7800210 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group A)
Number of subjects: 137
Study 7800210 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 137
Study 2843031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 0
Study 30016192 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training 2 times/week (G2X)
Number of subjects: 45
Study 30016192 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training 3 times/week (G3X)
Number of subjects: 45
Study 27774990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide 2.0 mg/day in cohort 1
Number of subjects: 96
Study 27774990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide 0.5 mg/day in cohort 2
Number of subjects: 96
Study 27774990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide 2.0 mg/day
Number of subjects: 96
Study 27774990 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutated TET2
Number of subjects: 96
Study 27774990 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide (both doses)
Number of subjects: 96
Study 26634922 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Decision Aid (CDA)
Number of subjects: 400
Study 26634922 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 400
Study 23435671 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine/erlotinib followed by capecitabine
Number of subjects: 173
Study 23435671 — intervention group
Group type: COMPARATOR
Intervention: capecitabine/erlotinib followed by gemcitabine
Number of subjects: 173
Study 23435671 — intervention group
Group type: COMPARATOR
Intervention: non-erlotinib containing 2nd-line chemotherapy
Number of subjects: 173
Study 22078721 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin (80-90 mg/kg per day or 375 mg twice a day for infants aged 2-11 months and 625 mg twice a day for those aged 12-59 months)
Number of subjects: 1995
Study 22078721 — intervention group
Group type: COMPARATOR
Intervention: First dose of oral co-trimoxazole (sulfamethoxazole 200 mg plus trimethoprim 40 mg for age 2-11 months; sulfamethoxazole 300 mg plus trimethoprim 60 mg for age 12 months to 5 years) and referral to health facility
Number of subjects: 1995
Study 22078721 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin
Number of subjects: 1995
Study 22078721 — intervention group
Group type: COMPARATOR
Intervention: Oral co-trimoxazole
Number of subjects: 1995
Study 19321570 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (50 mg/d) with vitamin D (16 microg/d) and calcium (700 mg/d) in women
Number of subjects: 113
Study 19321570 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (50 mg/d) with vitamin D (16 microg/d) and calcium (700 mg/d) in men
Number of subjects: 113
Study 19321570 — intervention group
Group type: COMPARATOR
Intervention: Placebo with vitamin D (16 microg/d) and calcium (700 mg/d) in women
Number of subjects: 113
Study 19321570 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (50 mg/d)
Number of subjects: 113
Study 19321570 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (50 mg/d) and placebo
Number of subjects: 113
Study 16765957 — intervention group
Group type: EXPERIMENTAL
Intervention: navMIS-DHS
Number of subjects: 78
Study 16765957 — intervention group
Group type: COMPARATOR
Intervention: conv-DHS
Number of subjects: 78
Study 16765957 — intervention group
Group type: COMPARATOR
Intervention: nav-DHS
Number of subjects: 78
Study 16296368 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 0.6 mg x kg(‐1) administered immediately after HB administration
Number of subjects: 17
Study 16296368 — intervention group
Group type: COMPARATOR
Intervention: Control group (no esmolol)
Number of subjects: 17
Study 16296368 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (E and C)
Number of subjects: 17
Study 11912566 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily)
Number of subjects: 15
Study 11912566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9567633 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg‐1 of lidocaine
Number of subjects: 40
Study 9567633 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg/kg‐1 of urapidil
Number of subjects: 40
Study 7882275 — intervention group
Group type: EXPERIMENTAL
Intervention: MFL (methotrexate, 5-FU, leucovorin)
Number of subjects: 178
Study 7882275 — intervention group
Group type: EXPERIMENTAL
Intervention: FL (5-FU and leucovorin)
Number of subjects: 178
Study 7882275 — intervention group
Group type: COMPARATOR
Intervention: F (5-FU alone)
Number of subjects: 178
Study 1973940 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamilton Rating Scale for Anxiety and Hamilton Rating Scale for Depression
Number of subjects: 3000
Study 1973940 — intervention group
Group type: COMPARATOR
Intervention: Hopkins Symptom Checklist
Number of subjects: 3000
Study 776551 — intervention group
Group type: EXPERIMENTAL
Intervention: Central electrical stimulation and relaxation
Number of subjects: 0
Study 776551 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic peripheral stimulation and relaxation
Number of subjects: 0
Study 776551 — intervention group
Group type: COMPARATOR
Intervention: Relaxation only
Number of subjects: 0
Study 776551 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular periods of relaxation
Number of subjects: 0
Study 776551 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized somatic and psychotherapeutic methods
Number of subjects: 0
Study 31401877 — intervention group
Group type: EXPERIMENTAL
Intervention: Reveal group (sFlt‐1/PlGF result known to clinicians)
Number of subjects: 370
Study 31401877 — intervention group
Group type: COMPARATOR
Intervention: Nonreveal group (sFlt‐1/PlGF result unknown)
Number of subjects: 370
Study 31401877 — intervention group
Group type: EXPERIMENTAL
Intervention: sFlt‐1/PlGF ratio test
Number of subjects: 370
Study 31401877 — intervention group
Group type: COMPARATOR
Intervention: Clinical practice alone
Number of subjects: 370
Study 31401877 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 370
Study 28467113 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Glargine 300 U/mL (Gla-300)
Number of subjects: 0
Study 28467113 — intervention group
Group type: COMPARATOR
Intervention: Insulin Glargine 100 U/mL (Gla-100)
Number of subjects: 0
Study 26051728 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics combined with triple therapy
Number of subjects: 132
Study 26051728 — intervention group
Group type: COMPARATOR
Intervention: Traditional triple therapy
Number of subjects: 132
Study 24359618 — intervention group
Group type: EXPERIMENTAL
Intervention: FOCUS Harmonic Scalpel
Number of subjects: 778
Study 24359618 — intervention group
Group type: COMPARATOR
Intervention: Conventional clamp-and-tie technique
Number of subjects: 778
Study 21545917 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscope training session before the clerkship (study group, n = 36)
Number of subjects: 70
Study 21545917 — intervention group
Group type: COMPARATOR
Intervention: No training (control group, n = 36)
Number of subjects: 70
Study 19423416 — intervention group
Group type: EXPERIMENTAL
Intervention: GNRB arthrometer
Number of subjects: 45
Study 19423416 — intervention group
Group type: COMPARATOR
Intervention: KT‐1000 arthrometer
Number of subjects: 45
Study 17090560 — intervention group
Group type: EXPERIMENTAL
Intervention: Early switch to oral antibiotics after 3 days of intravenous antibiotics
Number of subjects: 265
Study 17090560 — intervention group
Group type: COMPARATOR
Intervention: Standard 7 day course of intravenous antibiotics
Number of subjects: 265
Study 14982610 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (120 microg total metered dose, 90 microg delivered dose)
Number of subjects: 12
Study 14982610 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (2000 microg total metered dose)
Number of subjects: 12
Study 14982610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11822474 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5% carbohydrate (CHO) solution
Number of subjects: 8
Study 11822474 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 8
Study 9468009 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily
Number of subjects: 0
Study 9468009 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg once daily
Number of subjects: 0
Study 7887144 — intervention group
Group type: EXPERIMENTAL
Intervention: Biotene toothpaste (lactoperoxidase-system-containing)
Number of subjects: 20
Study 7887144 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste (without lactoperoxidase, KSCN, and glucose oxidase)
Number of subjects: 20
Study 3349830 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoscopic protected catheter brush (BPCB)
Number of subjects: 27
Study 3349830 — intervention group
Group type: COMPARATOR
Intervention: Telescoping catheter brush (BFW brush 10/70/90)
Number of subjects: 27
Study 31718393 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Dot bystander-based prevention program
Number of subjects: 26
Study 31718393 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study 31387592 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (1000 mg/day)
Number of subjects: 20
Study 31387592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 28320789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained nurse home visiting (SNHV) programme with 25 home visits from pregnancy to child age 2 years.
Number of subjects: 722
Study 28320789 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard, universal Australian child and family health service).
Number of subjects: 722
Study 25431315 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy (education, participatory working groups, role models)
Number of subjects: 1649
Study 23246796 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered carotenoids
Number of subjects: 24
Study 23246796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21461326 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal EPAP device
Number of subjects: 250
Study 21461326 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 250
Study 18822021 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day
Number of subjects: 30
Study 16422731 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 14
Study 16422731 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthetics
Number of subjects: 14
Study 16422731 — intervention group
Group type: EXPERIMENTAL
Intervention: Entonox
Number of subjects: 14
Study 16422731 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs
Number of subjects: 14
Study 16422731 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 14
Study 12631530 — intervention group
Group type: EXPERIMENTAL
Intervention: LPD group
Number of subjects: 3
Study 12631530 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 3
Study 12631530 — intervention group
Group type: COMPARATOR
Intervention: RPD group
Number of subjects: 3
Study 10934071 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculosis incidence in the homeless population
Number of subjects: 2774
Study 10934071 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for tuberculosis
Number of subjects: 2774
Study 10934071 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmission patterns
Number of subjects: 2774
Study 10934071 — intervention group
Group type: EXPERIMENTAL
Intervention: Control measures
Number of subjects: 2774
Study 9360530 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypogonadal state (induced by leuprolide)
Number of subjects: 5
Study 9360530 — intervention group
Group type: COMPARATOR
Intervention: Eugonadal state (saline injections)
Number of subjects: 5
Study 9360530 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose testosterone (testosterone enanthate, 3 mg/kg.week)
Number of subjects: 5
Study 9360530 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanozolol (0.1 mg/kg.day)
Number of subjects: 5
Study 9360530 — intervention group
Group type: COMPARATOR
Intervention: Hypogonadal state vs Eugonadal state
Number of subjects: 5
Study 9360530 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose testosterone treatment
Number of subjects: 5
Study 10146806 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing about personal traumatic experiences
Number of subjects: 41
Study 10146806 — intervention group
Group type: COMPARATOR
Intervention: Writing about non-traumatic topics
Number of subjects: 41
Study 10146806 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional inhibition levels
Number of subjects: 41
Study 2865766 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement
Number of subjects: 10
Study 2865766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2865766 — intervention group
Group type: COMPARATOR
Intervention: Estrogen replacement and Placebo
Number of subjects: 10
Study 31536041 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinpocetine (2 mg/kg/day)
Number of subjects: 87
Study 31536041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 31536041 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinpocetine
Number of subjects: 87
Study 29724300 — intervention group
Group type: EXPERIMENTAL
Intervention: ramucirumab plus paclitaxel
Number of subjects: 48
Study 29724300 — intervention group
Group type: COMPARATOR
Intervention: paclitaxel only
Number of subjects: 48
Study 27512103 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (2 µg/kg per minute)
Number of subjects: 360
Study 27512103 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose nesiritide (0.005 μg/kg per minute without bolus)
Number of subjects: 360
Study 27512103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 24784909 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand group (n = 29)
Number of subjects: 60
Study 24784909 — intervention group
Group type: EXPERIMENTAL
Intervention: Step group (n = 31)
Number of subjects: 60
Study 21903032 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/d for 6 weeks (T0)
Number of subjects: 22
Study 21903032 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 30-50 mg/d for 6 weeks (T1)
Number of subjects: 22
Study 21903032 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine treatment responders
Number of subjects: 22
Study 21903032 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine treatment
Number of subjects: 22
Study 21903032 — intervention group
Group type: COMPARATOR
Intervention: Placebo dose escalation
Number of subjects: 22
Study 21034206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (grief therapy)
Number of subjects: 122
Study 21034206 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 122
Study 19019649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu laryngeal mask
Number of subjects: 200
Study 19019649 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Unique
Number of subjects: 200
Study 19019649 — intervention group
Group type: COMPARATOR
Intervention: Solus
Number of subjects: 200
Study 19019649 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft Seal
Number of subjects: 200
Study 16183994 — intervention group
Group type: EXPERIMENTAL
Intervention: Double embryo transfer
Number of subjects: 4
Study 16183994 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent transfer of a frozen embryo
Number of subjects: 4
Study 16183994 — intervention group
Group type: COMPARATOR
Intervention: Single embryo transfer
Number of subjects: 4
Study 12149523 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner led care
Number of subjects: 80
Study 12149523 — intervention group
Group type: COMPARATOR
Intervention: Doctor led care
Number of subjects: 80
Study 11574732 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilized polymyxin B fibers (PMX-F)
Number of subjects: 98
Study 9142020 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral nerve stimulation
Number of subjects: 77
Study 8273216 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (Group A)
Number of subjects: 29
Study 8273216 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Group A + B (no treatment control)
Number of subjects: 29
Study 8273216 — intervention group
Group type: COMPARATOR
Intervention: No treatment control (Group B)
Number of subjects: 29
Study 3551837 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 100 mg
Number of subjects: 38
Study 3551837 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg
Number of subjects: 38
Study 29385232 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutathione-PEGylated liposomal methylprednisolone (2B3-201)
Number of subjects: 24
Study 29385232 — intervention group
Group type: COMPARATOR
Intervention: Free methylprednisolone (active comparator)
Number of subjects: 24
Study 29385232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 28045799 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief communication skills training (CST) program based on cognitive behavioral therapy (CBT)
Number of subjects: 206
Study 26591680 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) therapy including Daoyin, Tuina, and acupotomology
Number of subjects: 120
Study 26591680 — intervention group
Group type: COMPARATOR
Intervention: Milwaukee brace
Number of subjects: 120
Study 23925758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa consumption for 30 days
Number of subjects: 60
Study 23925758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa consumption
Number of subjects: 60
Study 23925758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive measures (Mini‐Mental State Examination and Trail Making Test A and B)
Number of subjects: 60
Study 22008443 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic postconditioning (three cycles of 30 seconds of ischemia and 30 seconds of reperfusion)
Number of subjects: 80
Study 22008443 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic postconditioning
Number of subjects: 80
Study 22008443 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ischemic postconditioning)
Number of subjects: 80
Study 18055072 — intervention group
Group type: EXPERIMENTAL
Intervention: EP HIV-1090 vaccine (0.5, 2.0, or 4.0mg doses)
Number of subjects: 42
Study 18055072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 16933590 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable risperidone
Number of subjects: 115
Study 16933590 — intervention group
Group type: COMPARATOR
Intervention: Zuclopenthixol-depot
Number of subjects: 115
Study 12892853 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural therapy plus enriched treatment‐as‐usual (CBT‐ETAU)
Number of subjects: 42
Study 12892853 — intervention group
Group type: COMPARATOR
Intervention: Enriched treatment‐as‐usual only (ETAU)
Number of subjects: 42
Study 11192477 — intervention group
Group type: EXPERIMENTAL
Intervention: etodolac 400mg in solution, given as a single dose over 1 minute
Number of subjects: 24
Study 11192477 — intervention group
Group type: EXPERIMENTAL
Intervention: etodolac 400mg in divided doses over 30 minutes
Number of subjects: 24